Access our on-demand webinar.
With the ever-increasing number and complexity of available clinical pathology and biomarker assays, the value of dedicated clinical pathology expertise in both safety and clinical studies cannot be overstated. Integration of findings from multiple disciplines into a congruent narrative creates a natural mutual synergy between components of a toxicology report and has become an expectation in contemporary pharmaceutical development.
Instead of simply providing an arbitrary list of statistical differences or values falling out of historical range, clinical pathology data interpreted in the context of findings from other study endpoints (e.g., in-life, pathology, toxicokinetics) creates a natural mutual synergy between disciplines, strengthening the overall scientific value of toxicity studies reports.
This webinar will provide an overview of current clinical pathology reporting practices with emphasis on interpretation and integration of findings with other key study endpoints, including:
- In-life findings
- Veterinary observations
- Anatomic pathology findings
- Traditional and next-generation biomarkers
Complete the form to access this on-demand webinar.
